Pfizer Share Price
Start SIP in Pfizer
Start SIPPfizer Performance
Day Range
- Low 6,182
- High 6,275
52 Week Range
- Low 3,802
- High 6,451
- Open Price6,184
- Previous Close6,164
- Volume7700
Pfizer Investment Rating
-
Master Rating:
-
Pfizer (Nse) has an operating revenue of Rs. 2,224.67 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 34% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 32% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 563 | 547 | 540 | 575 | 531 | 573 |
| Operating Expenses Qtr Cr | 385 | 357 | 387 | 393 | 421 | 391 |
| Operating Profit Qtr Cr | 177 | 189 | 153 | 183 | 111 | 182 |
| Depreciation Qtr Cr | 15 | 14 | 18 | 15 | 16 | 26 |
| Interest Qtr Cr | 2 | 7 | 3 | 3 | 3 | 3 |
| Tax Qtr Cr | 52 | 65 | 46 | 52 | 32 | 35 |
| Net Profit Qtr Cr | 151 | 179 | 130 | 149 | 94 | 130 |
Pfizer Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹5,944.31
- 50 Day
- ₹5,564.57
- 100 Day
- ₹5,174.97
- 200 Day
- ₹4,793.59
- 20 Day
- ₹5,957.56
- 50 Day
- ₹5,447.67
- 100 Day
- ₹4,965.46
- 200 Day
- ₹4,642.06
Pfizer Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 6,266.13 |
| Second Resistance | 6,368.07 |
| Third Resistance | 6,436.13 |
| RSI | 67.00 |
| MFI | 66.64 |
| MACD Single Line | 196.81 |
| MACD | 191.34 |
| Support | |
|---|---|
| First Support | 6,096.13 |
| Second Support | 6,028.07 |
| Third Supoort | 5,926.13 |
Pfizer Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 169,173 | 14,278,201 | 84.4 |
| Week | 134,209 | 10,165,020 | 75.74 |
| 1 Month | 74,050 | 5,575,221 | 75.29 |
| 6 Month | 46,868 | 2,937,193 | 62.67 |
Pfizer Result Highlights
Pfizer Synopsis
NSE-Medical-Diversified
Pfizer Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2193.17 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2024. Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311.| Market Cap | 28,200 |
| Sales | 2,225 |
| Shares in Float | 1.65 |
| No of funds | 134 |
| Yield | 0.57 |
| Book Value | 7.84 |
| U/D Vol ratio | 3.4 |
| LTDebt / Equity | |
| Alpha | 0.16 |
| Beta | 0.32 |
Pfizer Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 63.92% | 63.92% | 63.92% | 63.92% |
| Mutual Funds | 8.32% | 7.72% | 7.61% | 7.39% |
| Insurance Companies | 7.4% | 7.44% | 7.52% | 7.57% |
| Foreign Portfolio Investors | 3.22% | 3.32% | 3.03% | 2.82% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.02% | 0.01% |
| Individual Investors | 12.55% | 12.9% | 13.2% | 13.61% |
| Others | 4.58% | 4.69% | 4.7% | 4.68% |
Pfizer Management
| Name | Designation |
|---|---|
| Mr. Pradip Shah | Chairman & Ind.Director |
| Ms. Meenakshi Nevatia | Managing Director |
| Mr. P Rengan | Executive Director - Operations |
| Mr. Amit Agarwal | Executive Director & CFO |
| Mr. Sunil Lalbhai | Independent Director |
| Mr. Uday Khanna | Independent Director |
| Ms. Meena Ganesh | Independent Director |
| Mr. Lakshmanan Krishnakumar | Independent Director |
| Ms. Sonia Singh | Independent Director |
Pfizer Forecast
Price Estimates
Pfizer Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-29 | Quarterly Results | |
| 2024-05-17 | Audited Results & Final Dividend | |
| 2024-02-09 | Quarterly Results | |
| 2023-10-28 | Quarterly Results | |
| 2023-08-11 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-21 | FINAL | Rs.35.00 per share(350%)Final Dividend |
| 2023-08-11 | FINAL | Rs.35.00 per share(350%)Final Dividend |
| 2023-08-11 | SPECIAL | Rs.5.00 per share(50%)Special Dividend |
| 2022-09-20 | SPECIAL | Rs.30.00 per share (300%) Special Interim Dividend |
| 2022-08-19 | FINAL | Rs.35.00 per share(350%)Dividend |
Pfizer FAQs
What is Share Price of Pfizer ?
Pfizer share price is ₹6,210 As on 09 September, 2024 | 09:57
What is the Market Cap of Pfizer ?
The Market Cap of Pfizer is ₹28410.2 Cr As on 09 September, 2024 | 09:57
What is the P/E ratio of Pfizer ?
The P/E ratio of Pfizer is 46.7 As on 09 September, 2024 | 09:57
What is the PB ratio of Pfizer ?
The PB ratio of Pfizer is 7.9 As on 09 September, 2024 | 09:57